Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
NSABP Foundation Inc
NSABP Foundation Inc
Fox Chase Cancer Center
American College of Radiology Imaging Network
Merck Sharp & Dohme LLC
Generic Devices Consulting, Inc.
Alliance for Clinical Trials in Oncology
University of Miami
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Hoosier Cancer Research Network
GERCOR - Multidisciplinary Oncology Cooperative Group
Gruppo Oncologico del Nord-Ovest
California Cancer Consortium
National Cancer Institute (NCI)
University of Southern California
University of Alabama at Birmingham
National Cancer Institute (NCI)
Novartis
Case Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris